Neuroselective transcutaneous electrical stimulation reveals neuronal sensitization in atopic dermatitis.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 19178984.
- Also identified by DOI 10.1016/j.jaad.2008.11.900.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The neuroselective transcutaneous electrical stimulator (NTES) can provoke itch and/or pain by the application of a 5-Hz alternating current. We sought to examine whether there is any difference in the perception of the stimulus evoked by the NTES between patients with atopic dermatitis (AD) and healthy control subjects. In all, 24 healthy control subjects and 24 patients with AD (nonlesional skin) were stimulated on 7 body sites using the NTES. Qualitative differences in the evoked perceptions and quantitative differences in the current intensity required to evoke perception were statistically analyzed. The NTES preferentially evoked itch in patients with AD. The current perception threshold was statistically lower in AD than in healthy control subjects on 3 body sites. Tests were performed on limited body areas. We demonstrated that the NTES can reveal neuronal sensitization to itch in nonlesional atopic skin.
Medical subject headings
- Dermatitis, Atopic
- Transcutaneous Electric Nerve Stimulation